A Q&A with Cormac Maher, MD, FAANS, FAAP, FACS; Division Chief, Pediatric Neurosurgery at Stanford Medicine Children’s Health ...
Dravet syndrome and other developmental epileptic encephalopathies are rare but devastating conditions that cause a host of ...
Gianna Cericola from Philidelphia said the first symptoms she noticed included a burning sensation when she went to the ...
Ultragenyx Pharmaceutical RARE reported fourth-quarter 2024 loss of $1.39 per share, wider than the Zacks Consensus Estimate ...
Cantor Fitzgerald reaffirmed its Overweight rating and $118.00 price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company specializing in rare diseases. Currently ...